BWXT Medical Submits Tc-99m Generator New Drug Application to FDA | News

OTTAWA, Ontario–( BUSINESS WIRE )–13. September 2022– BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the US Food and Drug Administration (FDA) requesting approval of their technetium-99m (Tc-99m) generator for diagnostic imaging. Once approved for commercial production by regulatory agencies, BWXT Medical’s new proprietary […]

Scroll to top